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Dementia causes massive cognitive, affec-
tive, and social impairment as well as
concomitant functional decline. Cogni-
tive interventions, together with pharma-
cological treatments, are acknowledged as
important tools to delay mental weakening
in dementing populations and to preserve
the life quality of patients and their rel-
atives (Prince et al., 2011; Woods et al.,
2012). Given the socioeconomic impact of
dementia on the health system, it is crit-
ical to assess cognitive intervention tech-
niques in terms of cost-efficiency (Hurd
et al., 2013). Nevertheless, most recent
reports have neglected this issue, showing
small, non-replicated, or even null results
(Olazarán et al., 2010). Arguably, this is
partly so because researchers are more spe-
cialized in the study of impairments than in
the design of intervention programs. Con-
sequently, there is no agreement on how
to define cognitive intervention or how to
measure its success (Giordano et al., 2010;
Fernández-Prado et al., 2012).
A problem implicitly evident in relevant
meta-analyses is that methodological deci-
sions affect the results’ reliability and repli-
cation (Bahar-Fuchs et al., 2013a). Usually,
an intervention program involves partic-
ipant inclusion criteria, pre-intervention
measurements, training sessions, post-
intervention measurements, and pre–post
statistical analyses to unravel the possible
intervention effects. However, systematic
methodological considerations for cogni-
tive intervention in dementia are scant
(Wollen, 2010). To increase the efficiency
of cognitive stimulation assessment, this
paper sets forth guidelines for cognitive
intervention design, control group for-
mation, control condition manipulation,
pre/post-intervention measurement, and
statistical analysis (see Table 1).
PARTICIPANTS
Participant selection is a critical issue,
which affects study design. First, the sample
size should be sufficiently large (approxi-
mately >100). This allows to control for
possible confounders and to prevent the
sample from becoming too small during
follow-up. However, this is often not easy
to achieve, given the difficulty to recruit
patients with similar clinical characteristics
(e.g., dementia subtype, pharmacological
treatment and doses, disease duration and
severity, and caregiver support). Current
reports usually consider really modest sam-
ples (Niu et al., 2010; Dröes et al., 2011;
Viola et al., 2011).
Different approaches should be consid-
ered for small and large groups. In small
groups, intervention should be focused and
specific (e.g., restricted to one cognitive
domain) and based on relevant pre/post
measures. For their own part, larger sam-
ples allow to track and control for con-
founding variables. Although a full clini-
cal characterization is always desirable, the
impact of these variables can be tracked
only with large sample sizes.
Moreover, depending on the demen-
tia subtype, diagnosis can be probable
[e.g., behavioral variant of frontotem-
poral dementia (bvFTD)] or confirmed
(e.g., Huntington’s disease with confirmed
mutation). For probable diagnosis, more
clinical/neuropsychological control mea-
sures should be considered. Moreover,
intervention effects can be subtle and dif-
ficult to identify in conditions with rapid
progression. Thus, different control and
intervention strategies should be applied
depending on diagnosis and sample size.
METHODOLOGICAL DESIGN
Intervention design is another critical
aspect. The assessment should be done by
specialists, with specific training on the
intervention program, and the evaluation
process should be monitored.
Regarding duration, the intervention
should be as intense as possible (e.g.,
daily and with a repeated design) to pro-
duce stronger effects relative to the pre-
intervention baseline (Kanaan et al., 2014).
In addition, the intervention should be
long enough to produce changes in the
assessed cognitive domains, but total dura-
tion should be reduced for small groups,
which have not been controlled for indi-
vidual differences). The longer the inter-
vention, the higher the probability that
uncontrolled individual/personal events
will affect the results (Luttenberger et al.,
2012).
Another important factor is specificity
versus generality. Interventions focused on
general aspects (quality of life and general
cognitive status) are more methodologi-
cally demanding, because of the complex-
ities of general skill training and measure-
ment (Carrion et al., 2013). Such situations
call for a more controlled, multi-measured,
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Table 1 | Relevant factors for improving research quality of cognitive interventions.
Participants Larger sample sizes allow for better control of confounding variables
The control and the intervention groups must be matched for critical clinical variables (dementia diagnosis, disease severity,
pharmacological treatment, caregiver support, etc.)
Methodological
design
The assessment should be performed by specialists with specific training on the intervention
The intervention should be as intense as possible and total duration should be long enough to produce changes in the assessed
cognitive domains
When interventions are focused on general aspects, a more controlled, multi-measured, and multivariate design with a large sample
size should be considered
Application manuals and standardized protocols are required in order to maximize training suitability and protocol comparability
Control group
and intervention
Both groups must be comparable regarding critical clinical variables that can affect cognition
Both groups should perform an activity that resembles the intervention in terms of intensity, duration, and social–physical
environments
Other confounding factors must be controlled for, such as adherence, incidental effects of external/personal events, and differences
in domains other than the content of intervention
Pre- and post-
measurements
Different evaluators should be considered to assess pre/post measures as well as cognitive intervention
Measures targeting the specific cognitive domain trained should be used alongside more general measures
Both self-reports from patients and caregivers and objective measures (ranging from neuropsychology and experimental design to
brain function techniques, such as fMRI or EEG) must be considered
Statistical
concerns
Statistical size effects are crucial in pre/post design
Multiple comparisons, multivariate designs, and corrections for multiple comparisons should be performed only with larger samples
For small samples, statistical assessment should be done at group-comparison level, with a focus on a single independent variable
indexing the intervention assessment
For small samples with a control group and pre/post assessment, analysis of multiple single cases should be a subsidiary strategy
and multivariate design (involving larger
samples). Training in specific domains
(e.g., working memory and emotional
recognition) can be simpler for several rea-
sons. There are relatively specific domains
differentially affected in certain dementia
subtypes [e.g., social cognition in bvFTD
(Ibanez and Manes, 2012); memory in
Alzheimer’s disease (Parra et al., 2009)].
In these cases, targeted interventions may
allow for more direct and intense train-
ing. Moreover, participant monitoring is
more straightforward, pre/post measures
can be directly related with the con-
tent of the intervention, and these effects
can be more easily tracked with specific
instruments.
Thus, intervention should be assessed
by trained and controlled professionals,
capable of assessing the trade-off between
intensity, duration, and specificity versus
generality in program design. A related
problem is the heterogeneity of the inter-
ventions and their poor descriptions.
Application manuals/handbooks and stan-
dardized protocols are required to maxi-
mize training efficiency and comparabil-
ity of protocols (Hunsley and Rumstein-
McKean, 1999; Town et al., 2012).
CONTROL GROUP AND CONTROL
VARIABLES
The inclusion of a control group and
control conditions increases the reliabil-
ity and validity of the results. Repeated
assessment and random aspects of per-
sonal experience have an impact on sev-
eral cognitive domains. Thus, differences
between pre- and post-measurements are
not informative on their own. A con-
trol group should always be consid-
ered and, if possible, subjects must
be randomly assigned to the experi-
mental and control groups. The mock
intervention or “placebo” effect usually
emerges in studies involving unspecific
social/recreational activities or no treat-
ment at all (Bahar-Fuchs et al., 2013b).
Control conditions should be carefully
designed in order to hone specific inter-
vention strategies.
Control group design should observe
the following requisites: (a) patient charac-
teristics should be measurable and compa-
rable among groups; (b) the activities per-
formed should be comparable with inter-
vention tasks regarding intensity, duration,
and social–physical environments; and (c)
confounding factors should be controlled.
Regarding the latter consideration, a gold
standard approach should monitor groups
regarding adherence, incidental effects of
external/personal events, and differences in
domains other than the one being assessed.
The patients and relatives’ self-report scales
and checklists prove very helpful for this
strategy. If sample size allows, relevant
individual differences should be measured
and controlled by means of statistical
comparisons. The patients’ progression
history, recent significant life events, and
everyday behavior (diet, exercise, social,
and recreational activities) should be con-
trolled by means of group comparisons or
multivariate analyses.
Therefore, the detection of
intervention-specific effects requires a
strict strategy including a truly comparable
control group, a monitoring process, and,
when possible, the control and weighing of
confounding variables.
PRE/POST MEASURES
The difference between pre- and post-
intervention measures is perhaps the most
important aspect to consider. A pre-
intervention measure (or baseline) allows
controlling for individual differences, and
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the effect of pre–post repetition can be
disentangled by including a control group
(Papp et al., 2009). Nevertheless, the most
important issue is how to quantify the
specific domain being trained.
One important factor is to favor the
similarity between the measurements and
the cognitive domain being tested. This
is easier to address when a specific
domain is being trained (e.g., working
memory) because the similarity between
the training and its measurement is
restricted to an isolated aspect, and can be
done by direct measurement of the task
performance. Nevertheless, when general
domains are considered (e.g., social func-
tioning), the distance between the inter-
vention and an isolated measure becomes
evident (Owen et al., 2010), requiring com-
plex or multiple measures (e.g., clinical
variables, cognitive screening, life qual-
ity assessment, functionality measures,
and relatives’ reports). A more ambitious
design should include specific and gen-
eral training as well as specific and gen-
eral pre/post-measurements. Note that a
design as such requires a larger sample
size, which is rarely observed in current
reports.
Another important sub-aspect is the
degree of objective measurement. Self-
reports are adequate to assess patients’
and relatives’ subjective experiences of
changes, but they lack objectivity and
can be biased by different factors. Sub-
jective reports should be accompanied
by objective (implicit and explicit) mea-
sures, ranging from experimental designs
to brain measures. Basic general cogni-
tive assessments (e.g., MMSE and fluid
intelligence) are usually considered in
intervention programs, but their gener-
ality renders them insensitive to subtle
changes.
Recent advances in translational cog-
nitive neuroscience are promissory. Neu-
roimaging methods have demonstrated the
sensitivity to training effects, suggesting
their potential role as systematic measures
of intervention success (Belleville et al.,
2011). Electromagnetic techniques offer a
simple, inexpensive approach to tap train-
ing effects (Vecchio et al., 2013; Yener
and Basar, 2013). Moreover, recent break-
throughs in engineering have given rise
to training-sensitive mathematical applica-
tions, such as the case of brain connectivity
measures (with both neuroimaging and
electromagnetic techniques) (Pievani et al.,
2011).
In brief, an adequate integrated
approach to assess cognitive interven-
tion effects requires the use of multi-level
measures (self-reports, neuropsychology,
and neuroscience) and a balance between
specificity and generality.
STATISTICAL ISSUES
Finally, statistical soundness is crucial
to attain reliability, validity, and replic-
ability. Although sample size and the
assessment of confounding variables drive
most of the considerations, there are
important decisions, which can bias the
results. First of all, statistical size effects
are more imperative in pre/post design
than in basic research. Thus, they should
be always reported, because they offer
direct information about the power of the
intervention.
Multiple comparisons and multivari-
ate designs should be considered only
with larger samples; otherwise, the sta-
tistical validity of the results will prove
highly questionable. Corrections for multi-
ple comparisons and selection of complex
statistical designs (e.g., structural equation
models, discriminant analysis, or support
vector machine) should also be restricted to
larger samples. Multi-site studies represent
a current solution to sample size problems.
For small samples, statistical assessment
should be done at group-comparison level.
The focus should be on a single inde-
pendent variable indexing the interven-
tion assessment. A valid alternative in the
context of small samples with a control
group and pre/post assessment would be
the analysis of multiple single cases (McIn-
tosh and Brooks, 2011; Sajjadi et al., 2013),
allowing a deeper examination of interven-
tion effects.
CONCLUSION
Much more knowledge is required to
understand the dramatic brain changes
triggered by dementia and the parallel
effects of training during cognitive inter-
vention. The assessment of patients with
dementia tends to underestimate several
methodological considerations, sometimes
yielding inconsistent, unreliable, or weak
results. Here, we have highlighted impor-
tant decisions, which may impact positively
on research quality (see Table 1 for a sum-
mary of these issues). An enhanced con-
trol and systematization of these issues
will improve our understanding of how
cognitive training affects the patients’ and
relatives’ quality of life.
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